Practical anticipation of human efficacious doses and pharmacokinetics using in vitro and preclinical in vivo data.
Accurate predictions of human pharmacokinetic and pharmacodynamic (PK/PD) profiles are critical in early drug development, as safe, efficacious, and "developable" dosing regimens of promising compounds have to be identified. While advantages of successful integration of preclinical PK/PD data in the "anticipation" of human doses (AHD) have been recognized, pharmaceutical scientists have faced difficulties with practical implementation, especially for PK/PD profile projections of compounds with challenging absorption, distribution, metabolism, excretion and formulation properties. In this article, practical projection approaches for formulation-dependent human PK/PD parameters and profiles of Biopharmaceutics Classification System classes I-IV drugs based on preclinical data are described. Case examples for "AHD" demonstrate the utility of preclinical and clinical PK/PD modeling for formulation risk identification, lead candidate differentiation, and prediction of clinical outcome. The application of allometric scaling methods and physiologically based pharmacokinetic approaches for clearance or volume of distribution projections is described using GastroPlus. Methods to enhance prediction confidence such as in vitro-in vivo extrapolations in clearance predictions using in vitro microsomal data are discussed. Examples for integration of clinical PK/PD and formulation data from frontrunner compounds via "reverse pharmacology strategies" that minimize uncertainty with PK/PD predictions are included. The use of integrated softwares such as GastroPlus in combination with established PK projection methods allow the projection of formulation-dependent preclinical and human PK/PD profiles required for compound differentiation and development risk assessments.
Heimbach
Tycho
T
DMPK-Translational Sciences, Novartis Institutes for BioMedical Research, One Health Plaza 436/3253, East Hanover, NJ 07470, USA. tycho.heimbach@novartis.com
Lakshminarayana
Suresh B
SB
Hu
Wenyu
W
He
Handan
H
D004305:Dose-Response Relationship, Drug; D015195:Drug Design; D006801:Humans; D066298:In Vitro Techniques; D010599:Pharmacokinetics
Clin Pharmacol Ther. 1996 Dec;60(6):601-7
8988062
J Pharmacokinet Pharmacodyn. 2005 Apr;32(2):185-97
16283534
Pharm Res. 1993 Jul;10(7):1093-5
8378254
Drug Metab Dispos. 1997 Dec;25(12):1329-36
9394021
Biopharm Drug Dispos. 1999 Apr;20(3):137-44
10211866
Mol Pharm. 2004 Jan 12;1(1):85-96
15832504
Biopharm Drug Dispos. 2008 Nov;29(8):455-68
18989850
Adv Drug Deliv Rev. 2008 Mar 17;60(6):717-33
18199522
J Pharm Sci. 2000 Jan;89(1):16-35
10664535
Drug Metab Dispos. 2007 Oct;35(10):1766-80
17620347
Adv Drug Deliv Rev. 2001 Oct 1;50 Suppl 1:S41-67
11576695
J Pharm Sci. 2006 Jun;95(6):1238-57
16639716
Xenobiotica. 2009 Sep;39(9):637-48
19480559
Pharm Res. 1998 Nov;15(11):1792-5
9834005
Drug Discov Today. 2009 Apr;14(7-8):358-72
19162219
J Pharm Sci. 2001 Apr;90(4):436-47
11170034
J Pharm Sci. 2005 Jun;94(6):1259-76
15858854
Drug Metab Dispos. 2005 Sep;33(9):1294-6
15919851
AAPS J. 2008 Dec;10(4):516-25
19002590
J Pharm Sci. 2003 Oct;92(10):1990-2007
14502539
J Pharm Sci. 2006 Aug;95(8):1810-21
16795002
Drug Metab Dispos. 2005 Sep;33(9):1297-303
15958605
J Pharm Sci. 2004 May;93(5):1165-75
15067693
Drug Metab Dispos. 2008 Jul;36(7):1385-405
18426954
J Pharmacol Exp Ther. 1997 Oct;283(1):46-58
9336307
Int J Pharm. 2004 Jan 9;269(1):241-9
14698595
Basic Clin Pharmacol Toxicol. 2005 Mar;96(3):193-9
15733214
Clin Pharmacol Ther. 1994 Oct;56(4):406-19
7955802
Clin Pharmacokinet. 2006;45(5):511-42
16640456
Pharm Res. 1995 Mar;12(3):413-20
7617530
Drug Metab Dispos. 2007 Oct;35(10):1886-93
17646280
J Pharm Sci. 2005 Jul;94(7):1396-417
15920764
Clin Pharmacokinet. 2006;45(12):1213-26
17112297
J Pharm Sci. 1979 Sep;68(9):1203-5
501558
J Clin Pharmacol. 2009 May;49(5):513-33
19299532
Cancer Chemother Rep. 1970 Apr;54(2):95-101
5003581
Science. 1949 Jun 10;109(2841):579-85
17835379
Pharm Res. 2005 Jan;22(1):103-12
15771236
Clin Pharmacokinet. 2008;47(1):35-45
18076217
Adv Drug Deliv Rev. 1996 Jun 12;19(3):359-76
11540095
Pharm Res. 2008 Apr;25(4):713-26
17899327
J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):235-49
11274893
AAPS J. 2009 Jun;11(2):225-37
19381840
Adv Drug Deliv Rev. 2007 Jul 30;59(7):591-602
17599644
Clin Pharmacokinet. 1999 Mar;36(3):211-31
10223169
Int J Clin Pharmacol Ther. 1997 Oct;35(10):401-13
9352388
Xenobiotica. 2007 Oct-Nov;37(10-11):1331-54
17968748
J Pharm Sci. 2004 Jul;93(7):1890-900
15176076
Expert Opin Drug Metab Toxicol. 2006 Aug;2(4):591-608
16859407